Annual Drug Patent Expirations for LOKELMA
Lokelma is a drug marketed by Astrazeneca and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting this drug.
Drug patent litigation for LOKELMA.
This drug has one hundred and sixteen patent family members in thirty-five countries.
The generic ingredient in LOKELMA is sodium zirconium cyclosilicate. Two suppliers are listed for this compound. Additional details are available on the sodium zirconium cyclosilicate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com